608 results on '"Fujii, Hideaki"'
Search Results
2. Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
3. Visible-light-Induced synthesis of imidazolidines through formal [3 + 2] cycloaddition of aromatic imines with N,N,N',N'-tetramethyldiaminomethane
4. Morphinan derivatives with an oxabicyclo[3.2.1]octane structure as dual agonists toward δ and κ opioid receptors
5. SYK-623, a δ Opioid Receptor Inverse Agonist, Mitigates Chronic Stress-Induced Behavioral Abnormalities and Disrupted Neurogenesis
6. Catalyst-free photooxidation reaction from 1,4-dihydropyridazine to pyridazine under air
7. The Inhibition of TREK-1 K + Channels via Multiple Compounds Contained in the Six Kamikihito Components, Potentially Stimulating Oxytocin Neuron Pathways.
8. Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol
9. Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator
10. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening
11. The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis
12. Author Correction: The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis
13. Chapter 1 - Recent progress in the construction of sp3-rich compound libraries with natural product-like properties
14. The application of a specific morphinan template to the synthesis of galanthamine
15. Deprotection of silyl ethers by using SO3H silica gel: Application to sugar, nucleoside, and alkaloid derivatives
16. The first structure-activity relationship study of oxytocin as a positive allosteric modulator for the µ opioid receptor
17. MicroRNA expression in the vildagliptin-treated two- and three-dimensional HepG2 cells
18. Synthesis and evaluation of novel opioid ligands with a C-homomorphinan skeleton
19. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain
20. Transformation of naltrexone into mesembrane and investigation of the binding properties of its intermediate derivatives to opioid receptors
21. Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways
22. <Symposium>'Issues of Use of Renewable Energy Sources and Transition to a Decarbonized Society'
23. Economic Measures for Evaluating CO2 Emission Reduction in Japan by Using the Integrated Model of Multi-sectoral Macroeconomy and Energy
24. Twin and Triplet Drugs in Opioid Research
25. Opioids in Preclinical and Clinical Trials
26. Synthesis of Novel Basic Skeletons Derived from Naltrexone
27. Human Nitrilase-like Protein Does Not Catalyze the Hydrolysis of Vildagliptin
28. Rational Drug Design of δ Opioid Receptor Agonist TAN-67 from δ Opioid Receptor Antagonist NTI
29. The most effective influence of 17-(3-ethoxypropyl) substituent on the binding affinity and the agonistic activity in KNT-127 derivatives, δ opioid receptor agonists
30. The Challenges and Prospects of Japan's Energy Security in East Asia since the 1990s
31. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton having a 7-amide side chain and their pharmacologies
32. Synthesis of quinolinomorphinan derivatives as highly selective δ opioid receptor ligands
33. Synthesis of quinolinomorphinan-4-ol derivatives as δ opioid receptor agonists
34. The Japanese Herbal Medicine Hangeshashinto Induces Oral Keratinocyte Migration by Mediating the Expression of CXCL12 Through the Activation of Extracellular Signal-Regulated Kinase
35. The First Structure-Activity Relationship Study of Oxytocin as a Positive Allosteric Modulator for the Μ Opioid Receptor
36. Visible-Light-Induced Formal [3+2] Cycloaddition of α, β-Unsaturated Imides or Amide with N,N,N',N'-Tetramethyldiaminomethane for the Synthesis of 4-Alkyl- and 4-Aryl-1-methyl-2-pyrrolidinones
37. Visible-Light-Induced Synthesis of Imidazolidines Through Formal [3+2] Cycloaddition of Aromatic Imines with N,N,N',N'-Tetramethyldiaminomethane
38. Effects of KNT-127, a delta opioid receptor agonist, on sleep in mice.
39. Effects of KNT-127, a delta opioid receptor agonist, on non-REM sleep in mice.
40. Synthesis of 6,14-epoxymorphinan derivatives and their pharmacologies
41. Rearrangement of 4,5α-epoxymorphinan derivatives with carbamoylepoxy rings provide novel oxazatricyclodecane structures
42. Morphinan derivatives with an oxabicyclo[3.2.1]octane structure as dual agonists toward δ and Κ opioid receptors
43. In Vitro Analyses of Spinach-Derived Opioid Peptides, Rubiscolins: Receptor Selectivity and Intracellular Activities through G Protein- and β-Arrestin-Mediated Pathways
44. Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway
45. Identification of the three-dimensional pharmacophore of κ-opioid receptor agonists
46. Identification of a Putative β‐Arrestin Superagonist of the Growth Hormone Secretagogue Receptor (GHSR)
47. CHANGING GLOBAL OIL MARKETS AND EMERGENCY OIL STOCKS FOR ASIAN ECONOMIES
48. Novel rearrangement reaction of a 6,14-endoethanomorphinan derivative to a benzomorphan derivative
49. Aerobic oxidation of indolomorphinan without the 4,5-epoxy bridge and subsequent rearrangement of the oxidation product to spiroindolinonyl- C-normorphinan derivative
50. Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.